Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 37
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair

Spatially restricted and ontogenically distinct hepatic...

 47

Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket

Targeting Ras-, Rho-, and Rab-family GTPases via a cons...

 63

A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability

A human gut bacterium antagonizes neighboring bacteria ...

 36